NUSATRIP Inc. Receives Nasdaq Delisting Notice for Untimely Financial Filings
Summary
NUSATRIP Inc. received a delinquency notification from Nasdaq for failing to timely file its 2025 Annual Report and Q1 2026 Quarterly Report, putting its Nasdaq listing at risk.
Key Events
-
Nasdaq Delisting Notice Received
On May 27, 2026, NUSATRIP Inc. received a delinquency notification from Nasdaq for non-compliance with Listing Rule 5250(c)(1), citing failure to timely file its Annual Report on Form 10-K for December 31, 2025, and Quarterly Report on Form 10-Q for March 31, 2026.
-
Compliance Deadlines Set
The company has 60 calendar days, until July 27, 2026, to submit a plan to regain compliance. If accepted, Nasdaq may grant up to 180 calendar days from the 10-K's due date, or until October 12, 2026, to fully regain compliance.
-
Company Response
NUSATRIP Inc. stated it is working diligently to complete and file the delinquent reports within the initial 60-day period to avoid the need for a formal compliance plan.
-
Context of Executive Changes
This delisting notice follows the immediate termination of the company's CEO and CFO for cause on May 20, 2026, suggesting potential links between the executive departures and the financial reporting failures.
Analysis
This is a critical development as NUSATRIP Inc. faces potential delisting from Nasdaq due to its failure to timely file its annual and quarterly financial reports. The inability to provide up-to-date financials is a major red flag for investors, signaling significant operational or governance issues. This notice follows closely on the heels of the termination of the previous CEO and CFO on May 20, 2026, suggesting a direct link between the executive changes and the company's financial reporting deficiencies. Regaining compliance is essential to maintain investor confidence and market access.
At the time of this filing, NUTR was trading at $9.00 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $169.4M. The 52-week trading range was $3.40 to $42.45. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.